AGL 38.20 Increased By ▲ 0.05 (0.13%)
AIRLINK 129.30 Increased By ▲ 4.23 (3.38%)
BOP 7.85 Increased By ▲ 1.00 (14.6%)
CNERGY 4.66 Increased By ▲ 0.21 (4.72%)
DCL 8.35 Increased By ▲ 0.44 (5.56%)
DFML 38.86 Increased By ▲ 1.52 (4.07%)
DGKC 82.20 Increased By ▲ 4.43 (5.7%)
FCCL 33.64 Increased By ▲ 3.06 (10.01%)
FFBL 75.75 Increased By ▲ 6.89 (10.01%)
FFL 12.83 Increased By ▲ 0.97 (8.18%)
HUBC 110.72 Increased By ▲ 6.22 (5.95%)
HUMNL 14.03 Increased By ▲ 0.54 (4%)
KEL 5.22 Increased By ▲ 0.57 (12.26%)
KOSM 7.69 Increased By ▲ 0.52 (7.25%)
MLCF 40.08 Increased By ▲ 3.64 (9.99%)
NBP 72.51 Increased By ▲ 6.59 (10%)
OGDC 189.18 Increased By ▲ 9.65 (5.38%)
PAEL 25.74 Increased By ▲ 1.31 (5.36%)
PIBTL 7.38 Increased By ▲ 0.23 (3.22%)
PPL 153.45 Increased By ▲ 9.75 (6.78%)
PRL 25.52 Increased By ▲ 1.20 (4.93%)
PTC 17.92 Increased By ▲ 1.52 (9.27%)
SEARL 82.50 Increased By ▲ 3.93 (5%)
TELE 7.63 Increased By ▲ 0.41 (5.68%)
TOMCL 32.50 Increased By ▲ 0.53 (1.66%)
TPLP 8.48 Increased By ▲ 0.35 (4.31%)
TREET 16.74 Increased By ▲ 0.61 (3.78%)
TRG 56.01 Increased By ▲ 1.35 (2.47%)
UNITY 28.85 Increased By ▲ 1.35 (4.91%)
WTL 1.34 Increased By ▲ 0.05 (3.88%)
BR100 10,659 Increased By 569.2 (5.64%)
BR30 31,331 Increased By 1822.5 (6.18%)
KSE100 99,269 Increased By 4695.1 (4.96%)
KSE30 31,032 Increased By 1587.6 (5.39%)
Business & Finance

Lahore based drug maker eyes to launch country’s biggest pharma IPO

  • As per Citi Pharma Chief Executive Officer Rizwan Ahmed, the pharma is expected to go public in a matter of six weeks.
Published February 19, 2021

In a bid to expand the company’s operations, Citi Pharma, the Lahore-based pharmaceutical plans to go public, in what is expected to be the biggest Initial Public Offering (IPO) by a pharmaceutical in Pakistan.

Seeking advantage of the rising trends at the Pakistan Stock Exchange (PSX), which was recently crowned among the best performing bourse in the world, Citi Pharma aims to raise over Rs 2.85 billion or USD18 million, reported Bloomberg.

The PSX started of 2021 on a bullish run as it emerged as the 2nd best performing market in the region and 7th best performing market in the world in the month of January.

“Historically we have seen healthy returns during the month of January and this month was no different. Infact KSE-100 returns (6.0%) have outperformed last 10-Yr average returns (4.1%) of January. The USD-based return for the month settled at 5.8%. 7MFY21 returns of the index have settled at 34.8% (USDbased: 41.4%),” stated Arif Habib Limited in its report.

Meanwhile, as per Citi Pharma Chief Executive Officer Rizwan Ahmed, the pharma is expected to go public in a matter of six weeks.

Back in 2018, pharmaceutical company AGP Limited successfully raised around Rs 2.8 billion from local, foreign and institutional investors'. Bids in book building were received in excess of Rs 5 billion. This OFS consisted of 35 million shares (20 million by OBS Pakistan and 15 million by Muller and Phipps Pakistan).

However, Citi Pharma wants to surpass AGP’s IPO target and as per the report plans to offer 35 percent of its equity by selling 72.7 million shares at Rs 28 per share.

The report stated that the company will use a majority chunk of its IPO funds to build a 50-bed hospital in Lahore, while the remaining be utilized to build two new plants, which will start operations by the end of this year.

Comments

Comments are closed.